{"SPADE_UN_16988": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_16988", "Peptide Name": "HN-1", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "TSPLNIHNGQKL", "Sequence Length": 12, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Not available", "N-terminal Modification": "fluorescein/ FITC/texas red", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C57H96N18O18", "Mass": 1321.48, "PI": 8.44, "Net Charge": 2, "Hydrophobicity": -0.75, "Half Life": "Mammalian:7.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Isolation of a peptide for targeted drug delivery into human head and neck solid tumors.", "Pubmed ID": "11118031", "Reference": "Cancer Res. 2000 Dec 1;60(23)6551-6.", "Author": "Hong FD, Clayman GL.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11118031"}], "Frequent Amino Acids": "LNG", "Absent Amino Acids": "ACDEFMORUVWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 4, "Polar Residues": 7, "Positive Residues": 2, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17800", "Similarity": 0.9166666666666666, "Sequence": "YSPLNIHNGQKL"}, {"SPADE_ID": "SPADE_UN_28544", "Similarity": 0.8, "Sequence": "KLGFENFLVKALKTVMHVPTSPLL"}, {"SPADE_ID": "SPADE_N_10073", "Similarity": 0.625, "Sequence": "DDMSVISELICTSPLDFIN"}]}}}